Background illustration for clinical trials search

Paid Clinical Trials Fayetteville

Discover 156 paid clinical trials in Fayetteville, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis

for
Distal Lateral Subungual Onychomycosis, Onychomycosis
Location: Fayetteville AR, Houston TX, Austin TX, Lynchburg VA,
Sponsor: Nail Genesis LLC

Sex: All

Age: 18 - 65

Code: NCT06074315

Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Bentonville AR, Rogers AR, Oklahoma City OK, Dallas TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: Fayetteville AR, Overland Park KS, Southlake TX,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase 3, Recruiting

Persona Revision Knee System Outcomes

for
Arthroplasty Complications, Infection, Knee Disease,
Location: Fayetteville AR, Little Rock AR, Granger IN,
Sponsor: Zimmer Biomet

Sex: All

Age: 18+

Code: NCT04821154

Recruiting

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Springdale AR, Houston TX, Birmingham AL, Louisville KY,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06635785

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Springdale AR, Tyler TX, Dallas TX, Lincoln NE,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05650632

Phase 1, Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Springdale AR, Little Rock AR, Oklahoma City OK,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Springdale AR, Jonesboro AR, Wichita KS, Dallas TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Springdale AR, Springfield MO, Tulsa OK, Little Rock AR,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Springdale AR, Jonesboro AR, Wichita KS, Tyler TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase 3, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Springdale AR, Little Rock AR, Wichita KS, Dallas TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, c-MET
Location: Springdale AR, Lincoln NE, Nashville TN, Knoxville TN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07155187

Phase 2, Phase 3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Springdale AR, Shreveport LA, Dallas TX, Omaha NE,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: Springdale AR, Shreveport LA, Fenton MO, Tyler TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase 3, Recruiting

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Springdale AR, Germantown TN, Tyler TX, St Louis MO,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Springdale AR, St Louis MO, Arlington TX, Omaha NE,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221357

Phase 2, Phase 3, Recruiting

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for
Breast Neoplasms, Neoplasm Metastasis
Location: Springdale AR, Springfield MO, Dallas TX, Tupelo MS,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07174336

Phase 3, Recruiting

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

for
Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer,
Location: Springdale AR, Fairfax VA, Miami FL, East Brunswick NJ,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07625644

Phase 3, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Springdale AR, Kansas City MO, Germantown TN,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase 3, Recruiting

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: Springdale AR, Kansas City MO, Abilene TX, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07525206

Phase 3, Recruiting